Advertisement

Topics

Latest "Paragon Biomedical" News Stories

00:57 EDT 24th October 2018 | BioPortfolio

Here are the most relevant search results for "Paragon Biomedical" found in our extensive news archives from over 250 global news sources.

More Information about Paragon Biomedical on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Paragon Biomedical for you to read. Along with our medical data and news we also list Paragon Biomedical Clinical Trials, which are updated daily. BioPortfolio also has a large database of Paragon Biomedical Companies for you to search.

Showing "Paragon Biomedical" News Articles 1–25 of 1,500+

Extremely Relevant

paragon (PGN) - It’s electrifying

Edison Investment Research - General Industrials - paragon: paragon’s continued strong growth is driven by the Electromobility division (Voltabox) and the smaller Mechanics division. With the Electronics division transitioning to a new generation of products that should return the division to double-digit growth in the medium term, paragon remains a high-growth technology innovator. Followin...


Relevant

Anleihen heute im Fokus: paragon, Stada, CA Immobilien

Automobilelektroniker paragon erwirbt die Mehrheit an SemVox, einem führenden B2B Technologielieferant für proaktive Assistenten, die auf Künstlicher Intelligenz und Maschinellem Lernen basieren. M...

Paragon 28® adds novel syndesmotic repair solution to its robust ankle fracture portfolio - ...

ENGLEWOOD, Colo., Aug. 31, 2018 /PRNewswire/ -- Since its inception, Paragon 28® has obsessed over every aspect of foot and ankle surgery. Committed to creating Read more...


NN pays $375mm for Paragon Medical

Diversified industrial firm NN Inc. is paying $375mm in cash to acquire private device maker Paragon Medical Inc.

paragon (PGN) - Accelerating progress

Edison Investment Research - General Industrials - paragon: paragon continues to make strong progress, with Q218 showing a clear acceleration that should enable increased group FY18 revenue guidance to be met. Voltabox is making strategic investments to augment organic growth, through the adjustment to the Triathlon supply contract and the purchase of Navitas. Although the former does not impact o...

Paragon BioTeck Reformulates Freshkote, Prompting Eyevance Acquisition

NewsThe company recently completed the reformulation for the Freshkote family of lubricant eye drops, purchased last week by Eyevance Pharmaceuticals.Contribute

Inc. Magazine Honors Concierge Medicine Company in 37th Annual List of America's Fastest ...

NEW YORK, Oct. 17, 2018 /PRNewswire/ -- Paragon Private Health ("Paragon"), the nation's best-in-class architect of personalized concierge health care programs, announced the company has Read more...

China Pioneer, a Medical Device Distributor, Pays $33 Million for Stake in Australia's Paragon Care

China Pioneer Pharma Holdings, a medical device distributor, paid $33.2 million for a 15% stake in Australia's Paragon Care, a medical device maker. The two companies plan to cross-sell products in their respective markets. Paragon said it would use the cash to fund acquisitions of healthcare businesses in Australia and New Zealand. Pioneer has not previously been involved in the Australia or New ...

Sarepta Therapeutics Enters Manufacturing Partnership With Paragon Bioservices

WASHINGTON (dpa-AFX) - Biopharmaceutical company Sarepta Therapeutics, Inc. (SRPT) said it has entered into a long-term strategic manufacturing partnership with Paragon Bioservices Inc.The manufac...

Critical Access Hospital Replaces Paragon with eClinicalWorks Acute Care EHR

Waverly Health Center, a 25-bed critical access hospital located in Waverly, Iowa is expanding its relationship with eClinicalWorks by replacing their existing EHR from Paragon Inpatient to eClinicalWorks Acute Care EHR and Revenue Cycle Management. This transition will reduce overall implementation costs while creating unified patient records in inpatient and outpatient communities while ensuri...

Laufende Fusionskontrollverfahren: The Paragon Fund II GmbH & Co. KG, München (D); mittelbarer Erwerb von mindestens 99% der Anteile sowie der Kontrolle über die UCB Innere Medizin GmbH & Co. KG, Monheim (D) und die UCB Primary Care GmbH, Monheim (D);

Datum der Anmeldung:07.08.2018Aktenzeichen:B3-119/18Unternehmen:The Paragon Fund II GmbH & Co. KG, München (D); mittelbarer Erwerb von mindestens 99% der Anteile sowie der Kontrolle über die UCB In...

Paragon Biosciences Announces $71.8 Million in New Investment for Portfolio Company Castle Creek Pharma

Paragon organizes new investment from Fidelity Management & Research Company and Valor Equity Partners for portfolio company Castle Creek Pharma CHICAGO (PRWEB) October 19, 2018 Paragon Biosciences (Paragon) today announced the completion of a new capital investment of $71.8 million for Castle Creek Pharma (Castle Creek), a Paragon portfolio company. Paragon builds innovative companies that b...

Jeff Aronin Named One of the 20 Most Influential Leaders in Healthcare for 2018

Paragon CEO Jeff Aronin Recognized by Insights Care Magazine as “Innovative Entrepreneur Putting Patients First” CHICAGO (PRWEB) October 01, 2018 Paragon Biosciences CEO Jeff Aronin was recently recognized by Insights Care magazine for his innovative leadership in the biosciences sector and for his work bringing life-altering drugs to patients in need. Jeff’s vision has led Paragon to the t...

Paragon BioTeck Reformulated FRESHKOTE®, Prompting Eyevance Acquisition

Paragon BioTeck, a privately held pharmaceutical and medical device company specializing in the development and commercialization of ophthalmic pharmaceuticals, devices and therapies, recently completed the reformulation for the FRESHKOTE® family of lubricant eye drops, purchased this week by Eyevance Pharmaceuticals. “We are pleased to ...

Paragon Bioservices Appoints CFO

Gerard Fleury brings more than 25 years of industry experience as a CFO, COO or CEO

Paragon Bioservices Makes Leadership Promotions

Both Deborah Wild and Ruby Hofmann appointed to SVP roles

Aerie Pharmaceuticals and DSM Biomedical Expand Collaboration Agreement

Aerie Pharmaceuticals (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, retina diseases and other diseases of the eye, and DSM Biomedical a global solutions provider in biomedical science and regenerative medicine, today reported that they have expanded ...

Paragon Enters Mfg. Partnership with Sarepta

Deal expands commercial capacity for Sarepta’s micro-dystrophin gene therapy program

New Bionow Service Company of the Year Award to recognise excellence in specialist biomedical service provision and submission deadline extension

Applications are invited from specialist biomedical service companies who meet the criteria detailed in the award application form available at http://www.bionow.co.uk/events/bionowannualawardsdinner.aspx. The new award complements the award categories already announced and detailed below and highlights the breadth and strength of the offering of the biomedical cluster across the North.Biomed...

Biomedical CRO Biocytogen raises $65.3m

Biocytogen has raised $65.3m as part of a Series C funding round to scale its biomedical research and development services.

Capillary Biomedical gets $2.9M boost

Capillary Biomedical has closed a round of seed financing led by Cove Fund, generating $2.9 million in proceeds.  -More- 

Aerie, DSM Biomedical expand drug-delivery R&D deal

Aerie Pharmaceuticals has secured an exclusive global license to DSM Biomedical's polyesteramide polymer technology for any n -More- 

ArunA biomedical study published in Stroke, exosomes improved recovery in stroked pigs

(MacDougall Biomedical Communications, Inc.) ArunA Biomedical announces publication of study in Stroke that reports exosomes improved tissue and functional recovery in pig model of ischemic stroke.

Transforming biomedical innovation into enterprise

The Biomedical Innovation Hub is a brand new, fully serviced biomedical laboratory specifically designed to provide entrepreneurs and innovative start-ups with access to affordable laboratory facilities and equipment. During BioTrinity, Helen Miller-Viney, Business Development Manager, explained to Fintan Walton how this facility will provide laboratory space and guidance for start-up companies a...

Guten Morgen mit VW, SFC Energy, Daimler, Medigene und paragon

BBHDeutsche Balaton - Prognose GJ für IFRS-Eigenkapital vermutlich im unteren Bereich der prognos zierten Bandbreite BIO3Biotest gibt Abschluss des gegensei gen Anerkennungsverfahrens zur Marktzula...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks